IPO

Amanta Healthcare Limited IPO

Mainboard

Pharmaceuticals

Listed On: Sep 9, 2025 at ₹ 135.0(NSE)

₹ 14994 /119 Shares

Check Allotment

01 Sep, 2025

Open Date

03 Sep, 2025

Close Date

04 Sep, 2025

Allotment Date

09 Sep, 2025

Listing Date
Price Summary

Last Closing

125.01 (-0.79%)

52 Week High

154.40

52 Week Low

119.79

Last Update

20-Oct-2025 3:30 PM
Amanta Healthcare IPO Live Subscription Details
View Subscription Details
QIB 35.86x
Retail 54.98x
NIIs 209.42x
BHNI 226.13x
SHNI 176.02x
Retail 54.98x
Total 82.61x
Last updated: 03 Sep 2025, 06:50 PM
Amanta Healthcare IPO Issue Details
  • Issue Price ₹120-126 per equity share
  • Face Value ₹10 Per Equity Share
  • Total Issue Size 1,00,00,000 shares(aggregating up to ₹126 crore)
  • Fresh Share 1,00,00,000 shares(aggregating up to ₹126 crore)
  • Listing at BSE, NSE
  • List Price 135.0(NSE)
  • Listing Date 2025-09-09
  • Lead Manager Beeline Capital Advisors Pvt Ltd
  • Registrar MUFG Intime India Pvt Ltd
Market Lot Size

Investors can bid for a minimum of 119 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Retail Investors and HNI in terms of shares and amount.

ApplicationLotsSharesAmount
Retail (min)1119₹14,994
Retail(max)131,547₹1,94,922
SHNI(min) 141,666₹2,09,916
SHNI(max) 667,854₹9,89,604
BHNI(min) 677,973₹10,04,598
Amanta Healthcare IPO Reservation

Amanta Healthcare IPO offers total 70,00,000 shares. Out of which 20,00,000 (20%) allocated to QIB, 15,00,000 (15%) allocated to NII,35,00,000 (50%) allocated to RII, NA (NA%) allocated to employees and 58,28,290 (30%) allocated to Anchor investors.

Investor CategoryShares OfferedMaximum Allottees
Anchor Investor Shares Offered58,28,290 (30%)
QIB Shares Offered20,00,000 (20%)
NII (HNI) Shares Offered15,00,000 (15%)
bNII < ₹10L10,00,000 (10%)
sNII < ₹10L5,00,000 (5%)
Retail Shares Offered35,00,000 (50%)
Employee Shares OfferedNA (NA%)
Total Shares Offered70,00,000 (100%)
Amanta Healthcare IPO Documents
DRHP
RHP
ANCHOR
Amanta Healthcare IPO Details


Amanta Healthcare IPO is a book-built issue of ₹126 crores, The total issue size is ₹126 crores. The IPO of Amanta Healthcare is priced at ₹120-126 per equity share, which has a face value of ₹10 Per Equity Share each, IPO bidding starts from Sep 1, 2025 and ends on Sep 3, 2025. The allotment for Amanta Healthcare IPO will be finalized on Sep 4, 2025. Amanta Healthcare IPO will be listed on BSE, NSE, with a tentative listing date fixed as Sep 9, 2025. The company shall list its equity shares on the BSE, NSE. MUFG Intime India Pvt Ltd is the registrar of the issue.

Retail investors can bid for a minimum of 119 shares, extendable to 14,994. S-HNIs will be able to bid for 1,666 shares at ₹2,09,916, while B-HNIs can also apply for a bid of 7,973 shares at ₹10,04,598. The book-running lead manager for the IPO is/are Beeline Capital Advisors Pvt Ltd.

The total issue ₹126 crore, comprising a fresh issue of 1,00,00,000 shares ₹126 crore
The Amanta Healthcare IPO sets its price band at 120-126 for each share. A single application for Amanta Healthcare Limited IPO must contain at least 119 shares. Sentiment investors need to invest a minimum of 119 through their retail account. For investors to prevent oversubscription issues, they should submit bids at the cutoff price, which estimates about ₹14,994 In order to participate in the sNII, investors must purchase at least 14 lots of 1,666 shares for ₹2,09,916, while the bNII requires 67 lots of 7,973 shares for an investment of ₹10,04,598.

Read More
Amanta Healthcare IPO Subscription Analysis And Details
Retail
54.96x
QIB
35.86x
NII
209.40x
bNII
226.13x
sNII
175.96x
Total
82.60x
As onQIBNII
bNII   sNII		RetailTotal
Shares Offered / Reserved20,00,00015,00,000
10,00,000    5,00,000		35,00,00070,00,000
Day 1 01-09-25 05:00 PM
0.04 x5.82
4.24 x   8.98 x		6.71 x4.61 x
Day 2 02-09-25 05:00 PM
0.53 x36.40
30.03 x   49.13 x		23.33 x19.62 x
Day 3 03-09-25 05:00 PM
35.86 x209.40
226.13 x   175.96 x		54.96 x82.60 x
Total No of Applications
14,07,987
Subscription on the basis of Applications
Retail:46.0x BHNI:45.0x SHNI:169.0x
Amanta Healthcare Valuations
EPS Pre IPO ₹3.64/-
EPS Post IPO ₹2.70/-
P/E Pre IPO 34.59
P/E Post IPO 46.59
ROE 12.42%
ROCE 13.72%
Debt/Equity 2.02
RoNW 10.89%
PAT Margin 3.86%
Price to Book Value 3.77
Amanta Healthcare Company Financials
In Crs.
In Cr.
31-Mar-2531-Mar-2431-Mar-23
Assets381.76352.12374.06
Revenue276.09281.61262.70
Profit After Tax10.503.63-2.11
Net Worth96.3966.2962.88
Reserves & Surplus67.5639.4636.05
Total Borrowing195.00205.23215.66
About Amanta Healthcare Company

Established in December 1994, Amanta Healthcare Limited is a pharma firm that focuses on the manufacturing, development, and marketing of a wide range of sterile liquid items, namely parenteral items, packaged in plastic containers using Aseptic Blow-Fill-Seal (ABFS) and Injection Stretch Blow Moulding (ISBM) technologies. The company also engages in the manufacturing of medical devices.The company produces formulations for fluid therapy, such as IV fluids, diluents, ophthalmic solutions, and respiratory care products. The company also sells irrigation solutions, first-aid items, and eye lubricants in the medical device market.

The company sells products through three business divisions:
National sales
International sales
Product partnering with several foreign and Indian pharma companies.

The company produces more than 45 generic items, selling them under their brand names in India through 320 stockists and distributors.The firm markets products in Africa, Latin America, the UK, and overseas. It has registered its products in 19 countries and meets numerous regulations. During Fiscal 2025, the firm shipped branded goods to 21 countries.

As of March 31, 2025, the firm employs a workforce of 1,718 at its formulation and development and quality laboratory.

Read More
Amanta Healthcare - Promoter(s)

Bhavesh Patel

Vishal Patel

Jayshreeben Patel

Jitendra Kumar Patel

Milcent Appliances Private Limited

Pre Issue Share Holding : 85.60%

Post Issue Share Holding : 63.56%

Amanta Healthcare IPO - Issue Objectives
1

Funding capital expenditure requirements for civil construction work and towards purchase of equipment, plant and machinery for setting up new manufacturing line of SteriPort at Hariyala, Kheda, Gujarat

2

Funding capital expenditure requirements towards civil construction work, purchase of equipment, plant and machinery for setting up new manufacturing line for SVP at Hariyala, Kheda, Gujarat

3

General corporate purposes

Amanta Healthcare IPO - Anchor Investors

Amanta Healthcare raises Rs 37.8 crore from anchor investors before Rs 126-crore IPO.

Out Sanshi Fund, Perpetuity Health to Wealth Rising Fund, Sunrise Investment Trust, and FinavenueFund came through its Small Cap Fund.Sanshi Fund, Perpetuity Health to Wealth Rising Fund, Sunrise Investment Trust, and Finavenue Capital Trust were some other institutional investors that came on board for the anchor book.

Amanta Healthcare IPO - Peers Comparison
P/B RatioP/E RatioRoNWRevenue(in Cr.)
Amanta Healthcare3.7746.510.9%276
Denis Chem1.5315.59.77%175
Strength
Established in 1994 with diversified pharmaceutical product portfolio
Advanced sterile liquid manufacturing across wide volume range
Certified facility with ISO, WHO-GMP, and advanced technologies
Experienced leadership with skilled, qualified employee base
Weakness
High customer concentration poses revenue stability and dependency risks
Delay in SteriPort/SVP expansion may impact growth plans
Sterile liquid products carry serious product liability exposure
Unsecured borrowings and personal guarantees increase financial vulnerability
Contact Details

Amanta Healthcare

8th Floor, Shaligram Corporates C.J. Marg Ambli, Ahmedabad, Gujarat, 380058

079 67777600

cs@amanta.co.in

https://www.amanta.co.in/

Registrar Contact Details

MUFG Intime India Private Limited (Link Intime)

+91-22-4918 6270

amantahealthcare.ipo@linkintime.co.in

https://in.mpms.mufg.com/Initial_Offer/public-issues.html